The Food and Drug Administration (FDA) has recently released two draft guidance documents (Artificial Intelligence-Enabled Device Software ...

A proposed FDA rule would set nicotine levels on tobacco products at less than half the current average and could save ...

The pharma giant is partnering with software firms to imagine new drugs, find targets, and design clinical trials ...

Next to artificial intelligence, weight-loss drugs have been one of the biggest themes investors latched onto in 2024. Eli ...

Scaling personalized therapies brings unique logistical challenges. Unlike mass-market drugs, these treatments require highly specific materials, stringent cold chain logistics and real-time ...

Hallucinations are a persistent problem in healthcare. Here's how GSK is using test-time compute scaling to improve its gen AI systems.

BioSpace recaps 2024’s top venture capital rounds in biopharma, from Xaira Therapeutics’ blockbuster $1B raise to ...

Companies from Johnson & Johnson to Eli Lilly, Amazon and Nvidia are announcing health-related deals at the JPMorgan Health ...

The AHA’s recently released “Building and Implementing an Artificial Intelligence Action Plan for Health Care” provides a ...

J.P. Morgan Healthcare Conference is officially underway, bringing the healthcare and biopharma industries' biggest wheelers ...

Nvidia partners with industry leaders in life sciences to use AI for drug discovery, genomics research, and healthcare innovation. Read more here.

ZKGPT, an emerging leader in AI-powered Web3 solutions, announces the release of its new Public API, marking a significant ...